AIM ImmunoTech AIM
NYSE AIM
$0.18 -0.01 (-5.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

AIM ImmunoTech (AIM) Asset Writedowns and Impairment (2024 - 2025)

Updated

AIM ImmunoTech (AIM) reported Asset Writedowns and Impairment of $441,000 for Q4 2025, compared with $2,000 a year earlier and up 437.8% from the prior quarter.

Analysis

AIM ImmunoTech (AIM) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends

For FY2025, AIM ImmunoTech posted Asset Writedowns and Impairment of $1.14 million.

  • Asset Writedowns and Impairment has a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
  • By year, Asset Writedowns and Impairment came in at $48,000 in FY2024 and $1.8 million in FY2021 (+64.4%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $82,000 (Q3 2025), $280,000 (Q2 2025) and $335,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 441,000.00
Sep 30, 2025 82,000.00
Jun 30, 2025 280,000.00
Mar 31, 2025 335,000.00
Dec 31, 2024 2,000.00
API Access

AIM ImmunoTech Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AIM&period=max&api_key=YOUR_API_KEY